Nanodropper Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 26

Nanodropper General Information

Description

Developer of a patient-centered adaptor designed to address barriers in eye disease management. The company's adapter is designed to reduce the volume of currently oversized eye drops, enabling healthcare providers, payers, and patients to minimize medication waste and costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 442 51st Avenue North West
  • Rochester, MN 55901
  • United States
+1 (507)
Primary Industry
Other Devices and Supplies
Other Industries
Drug Delivery
Corporate Office
  • 442 51st Avenue North West
  • Rochester, MN 55901
  • United States
+1 (507)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanodropper Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Accelerator/Incubator 13-Jun-2022 Completed Generating Revenue
15. Grant 21-Sep-2021 Completed Generating Revenue
14. Accelerator/Incubator Completed Generating Revenue
13. Accelerator/Incubator Completed Generating Revenue
12. Seed Round 19-Apr-2021 Completed Generating Revenue
11. Grant 30-Mar-2021 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
9. Seed Round 29-Dec-2020 Completed Generating Revenue
8. Grant 19-Aug-2020 $549K $25K Completed Generating Revenue
7. Grant 30-Jun-2020 $35.5K $25K Completed Generating Revenue
To view Nanodropper’s complete valuation and funding history, request access »

Nanodropper Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
Seed-3
Seed-2 206,696 $0.000010 $0.48 $0.48 1x $0.48 1.48%
Seed-1 98,832 $0.000010 $0.43 $0.43 1x $0.43 0.71%
To view Nanodropper’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nanodropper Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a patient-centered adaptor designed to address barriers in eye disease management. The company's adapter is
Other Devices and Supplies
Rochester, MN
12 As of 2025

Dallas, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanodropper Competitors (1)

One of Nanodropper’s competitors is Hyperion DeFi, a Formerly VC-backed company based in Dallas, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hyperion DeFi Formerly VC-backed Dallas, TX
You’re viewing 1 of 1 competitors. Get the full list »

Nanodropper Patents

Nanodropper Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1124339-S1 Flexible insert for ophthalmic solution squeeze bottle Active 10-Dec-2024
US-20260115039-A1 Droplet tracker system and method for ophthalmic medicine delivery confirmation Pending 28-Oct-2024
WO-2026096464-A1 Droplet tracker system and method for ophthalmic medicine delivery confirmation Pending 28-Oct-2024
EP-4770588-A1 Cartridge based spray applicator for ophthalmic medicine Pending 31-Aug-2023
US-20250073063-A1 Cartridge based spray applicator for ophthalmic medicine Pending 31-Aug-2023 A61F9/0026
To view Nanodropper’s complete patent history, request access »

Nanodropper Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanodropper Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Consortium for Technology & Innovation in Pediatrics Accelerator/Incubator
Minnesota Cup University
Austin Area Angels Angel Group Minority
Giant Voices Growth/Expansion Minority
Golden Seeds Venture Capital Minority
You’re viewing 5 of 26 investors. Get the full list »

Nanodropper Acquisitions (1)

Nanodropper’s most recent deal was a Merger/Acquisition with GentleDrop. The deal was made on 02-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GentleDrop 02-Jul-2026 Merger/Acquisition Therapeutic Devices
To view Nanodropper’s complete acquisitions history, request access »

Nanodropper FAQs

  • When was Nanodropper founded?

    Nanodropper was founded in 2018.

  • Where is Nanodropper headquartered?

    Nanodropper is headquartered in Rochester, MN.

  • What is the size of Nanodropper?

    Nanodropper has 12 total employees.

  • What industry is Nanodropper in?

    Nanodropper’s primary industry is Other Devices and Supplies.

  • Is Nanodropper a private or public company?

    Nanodropper is a Private company.

  • What is Nanodropper’s current revenue?

    The current revenue for Nanodropper is .

  • How much funding has Nanodropper raised over time?

    Nanodropper has raised $2.85M.

  • Who are Nanodropper’s investors?

    The Consortium for Technology & Innovation in Pediatrics, Minnesota Cup, Austin Area Angels, Giant Voices, and Golden Seeds are 5 of 26 investors who have invested in Nanodropper.

  • Who are Nanodropper’s competitors?

    Hyperion DeFi is a competitor of Nanodropper.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process